Phreesia (NYSE:PHR) Downgraded to Neutral Rating by Piper Sandler

Phreesia (NYSE:PHR) was downgraded by equities researchers at Piper Sandler from an “overweight” rating to a “neutral” rating in a research note issued to investors on Thursday. They currently have a $12.00 price objective on the stock. Piper Sandler’s price target would indicate a potential upside of 24.56% from the stock’s previous close.

Several other research firms have also recently issued reports on PHR. Canaccord Genuity Group decreased their target price on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $9.00 price target (down from $15.00) on shares of Phreesia in a research report on Wednesday, May 20th. Truist Financial set a $12.00 price target on shares of Phreesia in a research report on Thursday. KeyCorp dropped their price objective on shares of Phreesia from $15.00 to $12.00 and set an “overweight” rating on the stock in a research note on Monday, April 13th. Finally, DA Davidson reiterated a “buy” rating and set a $14.00 price objective on shares of Phreesia in a research note on Thursday. Nine analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $16.53.

Phreesia Trading Up 5.5%

Shares of PHR traded up $0.50 during mid-day trading on Thursday, hitting $9.63. The company had a trading volume of 3,759,465 shares, compared to its average volume of 1,825,877. The business’s 50-day simple moving average is $9.53 and its 200-day simple moving average is $13.69. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. Phreesia has a 1-year low of $7.77 and a 1-year high of $32.76. The stock has a market cap of $595.09 million, a PE ratio of 326.30 and a beta of 0.89.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The business had revenue of $130.94 million for the quarter, compared to analysts’ expectations of $130.08 million. During the same period last year, the company earned ($0.07) earnings per share. The company’s quarterly revenue was up 12.9% on a year-over-year basis. Sell-side analysts forecast that Phreesia will post 0.28 earnings per share for the current year.

Insider Activity at Phreesia

In related news, insider David Linetsky sold 8,332 shares of Phreesia stock in a transaction on Friday, April 10th. The shares were sold at an average price of $8.07, for a total value of $67,239.24. Following the completion of the sale, the insider owned 224,056 shares in the company, valued at approximately $1,808,131.92. The trade was a 3.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Yvonne Hui sold 10,063 shares of Phreesia stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $9.08, for a total transaction of $91,372.04. Following the completion of the sale, the insider owned 25,991 shares of the company’s stock, valued at approximately $235,998.28. This trade represents a 27.91% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 50,493 shares of company stock worth $461,983 in the last ninety days. 5.20% of the stock is currently owned by corporate insiders.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Raymond James Financial Inc. increased its stake in shares of Phreesia by 2.7% in the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock worth $400,000 after buying an additional 375 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of Phreesia by 1.3% in the third quarter. Alliancebernstein L.P. now owns 62,712 shares of the company’s stock worth $1,475,000 after buying an additional 812 shares during the last quarter. Van ECK Associates Corp increased its stake in shares of Phreesia by 78.7% in the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after buying an additional 1,102 shares during the last quarter. Arizona State Retirement System increased its stake in shares of Phreesia by 8.1% in the third quarter. Arizona State Retirement System now owns 17,608 shares of the company’s stock worth $414,000 after buying an additional 1,313 shares during the last quarter. Finally, Federated Hermes Inc. bought a new stake in shares of Phreesia in the third quarter worth $32,000. Institutional investors own 92.10% of the company’s stock.

More Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia reported fiscal Q1 2027 earnings of $0.05 per share, beating estimates of $0.02, while revenue of $130.94 million also edged past expectations and grew 12.9% year over year. Phreesia Announces First Quarter Fiscal 2027 Results
• Positive Sentiment: DA Davidson reaffirmed its Buy rating on Phreesia and set a $14 price target, implying meaningful upside from recent trading levels. DA Davidson Reiterates Buy Rating on Phreesia Inc. (PHR)
• Neutral Sentiment: Management also outlined fiscal 2027 revenue guidance of $510 million to $520 million while keeping adjusted EBITDA guidance at $125 million to $135 million, which suggests continued growth but no major surprise versus the earnings update. Phreesia, Inc. Q1 2027 Earnings Call Summary
• Negative Sentiment: Multiple law firms issued reminders about an ongoing shareholder class-action lawsuit alleging Phreesia made misleading statements about its growth outlook and Network Solutions segment, with a lead-plaintiff deadline of July 13, 2026. Deadline Approaching: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
• Negative Sentiment: The class-action filings and investor alerts may pressure sentiment by reinforcing legal risk and uncertainty around prior disclosures. Lost Money on Phreesia, Inc. (PHR)? Join Class Action Suit Seeking Recovery – Contact SueWallSt

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.